Member-only story
ZBH Just Outperformed Buy-and-Hold by 7x — And This Strategy Shows You Exactly How
A walk-forward validated momentum system on ZBH
Kryptera8 min read·Just now--
Download Here: ZBH QQE + TRIX (2005–2026) Walk-Forward Optimized Systematic Strategy
When most people think about trading medical device stocks, they think about fundamentals. FDA approvals. Earnings beats. Pipeline news. They buy and hold, ride the volatility, and hope the long-term story plays out.
But what if a purely systematic, rules-based strategy — one that never reads a single press release — could outperform that approach by more than 7 times over the same 2-decade period?
That is exactly what the ZBH QQE + TRIX strategy demonstrates.
From January 2005 to April 2026, a simple buy-and-hold position in Zimmer Biomet Holdings returned just 37.37%. The same $100,000 invested passively grew to roughly $137,000 over 21 years. Not Negative, but hardly inspiring — especially given that ZBH spent much of that period going nowhere, grinding sideways after its 2015 peak and never fully recovering.
The walk-forward optimized QQE + TRIX strategy returned 266.90% over the same period. That same $100,000 became $366,902. No earnings calls. No analyst upgrades. Just 2 indicators, a clean set of rules, and…
